Answers are grounded in this paper and cite their sources.
Key Points Partially HLA-matched third-party CMV-specific T cells provide long-term viral control in HSCT patients with resistant CMV infection. Viral control occurs in the setting of recovery of CD8+ terminally differentiated effector T cells.
No takes yet. Share an insight, caveat, or question.
Withers et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: